Liminal BioSciences Inc.LL
DelistedDelistedDelisted

Liminal BioSciences Inc.

8.50USDR
Last update at 2024 Feb 16, 12:03 UTC
USD
No trades
See on Supercharts

LMNL fundamentals

Key facts

Market capitalization
Founded1994
CEOBruce Philip Pritchard
About

Liminal BioSciences is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products. It specializes in discovering, developing, and commercializing novel small molecule compounds for respiratory, liver, and renal diseases. The company focuses specifically on developing solutions for rare and orphan diseases. Liminal BioSciences was founded in 1992 and is headquartered in Laval, Quebec.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24

Growth and Profitability

Company’s recent performance and margins

Performance
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
‪0.00‬
‪‪300.00 K‬‬
‪‪600.00 K‬‬
‪‪900.00 K‬‬
‪‪1.20 M‬‬
Actual
Estimate
Earnings
Next:Mar 13
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
‪−2.40‬
‪−1.80‬
‪−1.20‬
‪−0.60‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

LMNL does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.